Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 382

1.

A Mass Spectrometry Survey of Chromatin-Associated Proteins in Pluripotency and Early Lineage Commitment.

van Mierlo G, Wester RA, Marks H.

Proteomics. 2019 Jul;19(14):e1900047. doi: 10.1002/pmic.201900047. Epub 2019 Jul 3.

PMID:
31219242
2.

The Complexity of PRC2 Subcomplexes.

van Mierlo G, Veenstra GJC, Vermeulen M, Marks H.

Trends Cell Biol. 2019 Aug;29(8):660-671. doi: 10.1016/j.tcb.2019.05.004. Epub 2019 Jun 6. Review.

3.

A SERS approach for rapid detection of microRNA-17 in the picomolar range.

Schechinger M, Marks H, Mabbott S, Choudhury M, Cote' G.

Analyst. 2019 Jul 7;144(13):4033-4044. doi: 10.1039/c9an00653b. Epub 2019 May 30.

PMID:
31143920
4.

Publisher Correction: Epigenetic modulation of a hardwired 3D chromatin landscape in two naive states of pluripotency.

Atlasi Y, Megchelenbrink W, Peng T, Habibi E, Joshi O, Wang SY, Wang C, Logie C, Poser I, Marks H, Stunnenberg HG.

Nat Cell Biol. 2019 Jul;21(7):911-912. doi: 10.1038/s41556-019-0341-2.

PMID:
31097792
5.

Epigenetic modulation of a hardwired 3D chromatin landscape in two naive states of pluripotency.

Atlasi Y, Megchelenbrink W, Peng T, Habibi E, Joshi O, Wang SY, Wang C, Logie C, Poser I, Marks H, Stunnenberg HG.

Nat Cell Biol. 2019 May;21(5):568-578. doi: 10.1038/s41556-019-0310-9. Epub 2019 Apr 29. Erratum in: Nat Cell Biol. 2019 May 16;:.

PMID:
31036938
6.

Miniaturised interaction proteomics on a microfluidic platform with ultra-low input requirements.

Furlan C, Dirks RAM, Thomas PC, Jones RC, Wang J, Lynch M, Marks H, Vermeulen M.

Nat Commun. 2019 Apr 4;10(1):1525. doi: 10.1038/s41467-019-09533-y.

7.

Allele-specific RNA-seq expression profiling of imprinted genes in mouse isogenic pluripotent states.

Dirks RAM, van Mierlo G, Kerstens HHD, Bernardo AS, Kobolák J, Bock I, Maruotti J, Pedersen RA, Dinnyés A, Huynen MA, Jouneau A, Marks H.

Epigenetics Chromatin. 2019 Feb 15;12(1):14. doi: 10.1186/s13072-019-0259-8.

8.

Sensing, monitoring, and release of therapeutics: the translational journey of next generation bandages (Erratum).

Li Z, Marks H, Evans CL, Apiou-Sbirlea G.

J Biomed Opt. 2019 Feb;24(2):1. doi: 10.1117/1.JBO.24.2.029802.

9.

Sensing, monitoring, and release of therapeutics: the translational journey of next generation bandages.

Li Z, Marks H, Evans C, Apiou-Sbirlea G.

J Biomed Opt. 2018 Dec;24(2):1-9. doi: 10.1117/1.JBO.24.2.021201. Erratum in: J Biomed Opt. 2019 Feb;24(2):1.

10.

Integrative Proteomic Profiling Reveals PRC2-Dependent Epigenetic Crosstalk Maintains Ground-State Pluripotency.

van Mierlo G, Dirks RAM, De Clerck L, Brinkman AB, Huth M, Kloet SL, Saksouk N, Kroeze LI, Willems S, Farlik M, Bock C, Jansen JH, Deforce D, Vermeulen M, Déjardin J, Dhaenens M, Marks H.

Cell Stem Cell. 2019 Jan 3;24(1):123-137.e8. doi: 10.1016/j.stem.2018.10.017. Epub 2018 Nov 21.

PMID:
30472157
11.

Quantitative subcellular proteomics using SILAC reveals enhanced metabolic buffering in the pluripotent ground state.

van Mierlo G, Wester RA, Marks H.

Stem Cell Res. 2018 Dec;33:135-145. doi: 10.1016/j.scr.2018.09.017. Epub 2018 Sep 24.

12.

Mammalian embryo comparison identifies novel pluripotency genes associated with the naïve or primed state.

Bernardo AS, Jouneau A, Marks H, Kensche P, Kobolak J, Freude K, Hall V, Feher A, Polgar Z, Sartori C, Bock I, Louet C, Faial T, Kerstens HHD, Bouissou C, Parsonage G, Mashayekhi K, Smith JC, Lazzari G, Hyttel P, Stunnenberg HG, Huynen M, Pedersen RA, Dinnyes A.

Biol Open. 2018 Aug 17;7(8). pii: bio033282. doi: 10.1242/bio.033282.

13.

MTF2 recruits Polycomb Repressive Complex 2 by helical-shape-selective DNA binding.

Perino M, van Mierlo G, Karemaker ID, van Genesen S, Vermeulen M, Marks H, van Heeringen SJ, Veenstra GJC.

Nat Genet. 2018 Jul;50(7):1002-1010. doi: 10.1038/s41588-018-0134-8. Epub 2018 May 28.

PMID:
29808031
14.

Development of a miRNA surface-enhanced Raman scattering assay using benchtop and handheld Raman systems.

Schechinger M, Marks H, Locke A, Choudhury M, Cote G.

J Biomed Opt. 2018 Jan;23(1):1-11. doi: 10.1117/1.JBO.23.1.017002.

15.

An efficient method for generation of bi-allelic null mutant mouse embryonic stem cells and its application for investigating epigenetic modifiers.

Fisher CL, Marks H, Cho LT, Andrews R, Wormald S, Carroll T, Iyer V, Tate P, Rosen B, Stunnenberg HG, Fisher AG, Skarnes WC.

Nucleic Acids Res. 2017 Dec 1;45(21):e174. doi: 10.1093/nar/gkx811.

16.

A magneto-fluidic nanoparticle trapping platform for surface-enhanced Raman spectroscopy.

Huang PJ, Marks HL, Coté GL, Kameoka J.

Biomicrofluidics. 2017 Jun 7;11(3):034116. doi: 10.1063/1.4985071. eCollection 2017 May.

17.

Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells.

Xu YM, Wijeratne EMK, Babyak AL, Marks HR, Brooks AD, Tewary P, Xuan LJ, Wang WQ, Sayers TJ, Gunatilaka AAL.

J Nat Prod. 2017 Jul 28;80(7):1981-1991. doi: 10.1021/acs.jnatprod.6b01129. Epub 2017 Jun 15.

PMID:
28617598
18.

Rapid isolation of blood plasma using a cascaded inertial microfluidic device.

Robinson M, Marks H, Hinsdale T, Maitland K, Coté G.

Biomicrofluidics. 2017 Mar 24;11(2):024109. doi: 10.1063/1.4979198. eCollection 2017 Mar.

19.

Tracking the embryonic stem cell transition from ground state pluripotency.

Kalkan T, Olova N, Roode M, Mulas C, Lee HJ, Nett I, Marks H, Walker R, Stunnenberg HG, Lilley KS, Nichols J, Reik W, Bertone P, Smith A.

Development. 2017 Apr 1;144(7):1221-1234. doi: 10.1242/dev.142711. Epub 2017 Feb 7.

20.

Modeling Rabbit Responses to Single and Multiple Aerosol Exposures of Bacillus anthracis Spores.

Coleman ME, Marks HM, Bartrand TA, Donahue DW, Hines SA, Comer JE, Taft SC.

Risk Anal. 2017 May;37(5):943-957. doi: 10.1111/risa.12688. Epub 2017 Jan 25.

21.

Ferric plasmonic nanoparticles, aptamers, and magnetofluidic chips: toward the development of diagnostic surface-enhanced Raman spectroscopy assays.

Marks H, Huang PJ, Mabbott S, Graham D, Kameoka J, Coté G.

J Biomed Opt. 2016 Dec 1;21(12):127005. doi: 10.1117/1.JBO.21.12.127005.

22.

Genome-wide epigenomic profiling for biomarker discovery.

Dirks RA, Stunnenberg HG, Marks H.

Clin Epigenetics. 2016 Nov 21;8:122. eCollection 2016. Review.

23.

Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies.

Ding X, Ray Chaudhuri A, Callen E, Pang Y, Biswas K, Klarmann KD, Martin BK, Burkett S, Cleveland L, Stauffer S, Sullivan T, Dewan A, Marks H, Tubbs AT, Wong N, Buehler E, Akagi K, Martin SE, Keller JR, Nussenzweig A, Sharan SK.

Nat Commun. 2016 Aug 8;7:12425. doi: 10.1038/ncomms12425.

24.

Catalytic and substrate promiscuity: distinct multiple chemistries catalysed by the phosphatase domain of receptor protein tyrosine phosphatase.

Srinivasan B, Marks H, Mitra S, Smalley DM, Skolnick J.

Biochem J. 2016 Jul 15;473(14):2165-77. doi: 10.1042/BCJ20160289. Epub 2016 May 17.

25.

History of the Athens Canadian Random Bred and the Athens Random Bred control populations.

Collins KE, Marks HL, Aggrey SE, Lacy MP, Wilson JL.

Poult Sci. 2016 May;95(5):997-1004. doi: 10.3382/ps/pew085. Epub 2016 Mar 14.

PMID:
26976904
26.

Erratum to: Dynamics of gene silencing during X inactivation using allele-specific RNA-seq.

Marks H, Kerstens HH, Barakat TS, Splinter E, Dirks RA, van Mierlo G, Joshi O, Wang SY, Babak T, Albers CA, Kalkan T, Smith A, Jouneau A, de Laat W, Gribnau J, Stunnenberg HG.

Genome Biol. 2016 Feb 5;17:22. doi: 10.1186/s13059-016-0885-4. No abstract available.

27.

Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis.

Goldenthal MJ, Damle S, Sheth S, Shah N, Melvin J, Jethva R, Hardison H, Marks H, Legido A.

Biomark Med. 2015;9(10):957-65. doi: 10.2217/bmm.15.72. Epub 2015 Oct 6.

PMID:
26439018
28.

Dynamics of gene silencing during X inactivation using allele-specific RNA-seq.

Marks H, Kerstens HH, Barakat TS, Splinter E, Dirks RA, van Mierlo G, Joshi O, Wang SY, Babak T, Albers CA, Kalkan T, Smith A, Jouneau A, de Laat W, Gribnau J, Stunnenberg HG.

Genome Biol. 2015 Aug 3;16:149. doi: 10.1186/s13059-015-0698-x. Erratum in: Genome Biol. 2016;17:22.

29.

Parents' experiences, needs, and preferences in pediatric diabetes care: Suggestions for improvement of care and the possible role of the Internet. A qualitative study.

Boogerd EA, Maas-van Schaaijk NM, Noordam C, Marks HJ, Verhaak CM.

J Spec Pediatr Nurs. 2015 Jul;20(3):218-29. doi: 10.1111/jspn.12118. Epub 2015 Jun 15.

PMID:
26076888
30.

Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27.

Tsuda T, Fitzgerald K, Scavena M, Gidding S, Cox MO, Marks H, Flanigan KM, Moore SA.

J Hum Genet. 2015 Mar;60(3):151-5. doi: 10.1038/jhg.2014.112. Epub 2014 Dec 24.

31.

Rational design of a bisphenol A aptamer selective surface-enhanced Raman scattering nanoprobe.

Marks HL, Pishko MV, Jackson GW, Coté GL.

Anal Chem. 2014 Dec 2;86(23):11614-9. doi: 10.1021/ac502541v. Epub 2014 Nov 10.

32.

Otx2 and Oct4 drive early enhancer activation during embryonic stem cell transition from naive pluripotency.

Yang SH, Kalkan T, Morissroe C, Marks H, Stunnenberg H, Smith A, Sharrocks AD.

Cell Rep. 2014 Jun 26;7(6):1968-81. doi: 10.1016/j.celrep.2014.05.037. Epub 2014 Jun 12.

33.

Stable methylation at promoters distinguishes epiblast stem cells from embryonic stem cells and the in vivo epiblasts.

Veillard AC, Marks H, Bernardo AS, Jouneau L, Laloë D, Boulanger L, Kaan A, Brochard V, Tosolini M, Pedersen R, Stunnenberg H, Jouneau A.

Stem Cells Dev. 2014 Sep 1;23(17):2014-29. doi: 10.1089/scd.2013.0639. Epub 2014 Jun 12.

34.

Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.

Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks HJ, Neumeyer M, Nathan T, Fernández-Bañares F, Greinwald R, Mohrbacher R, Vieth M, Bonderup OK; BUC-60/COC Study Group.

Gastroenterology. 2014 May;146(5):1222-30.e1-2. doi: 10.1053/j.gastro.2014.01.019. Epub 2014 Jan 15.

35.

Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.

Denissov S, Hofemeister H, Marks H, Kranz A, Ciotta G, Singh S, Anastassiadis K, Stunnenberg HG, Stewart AF.

Development. 2014 Feb;141(3):526-37. doi: 10.1242/dev.102681. Epub 2014 Jan 14.

36.

Tracking Breeds Success: Improved Retrieval Rates of Inferior Vena Cava Filters with Minimal Dedication of Resources.

Kalish J, Sloan M, Sarosiek S, Marks H, Moreira C, Hamburg N, Vilvendhan R, Farber A.

J Vasc Surg Venous Lymphat Disord. 2014 Jan;2(1):117. doi: 10.1016/j.jvsv.2013.10.043. Epub 2013 Dec 12. No abstract available.

PMID:
26993020
37.

Recessive TTN truncating mutations define novel forms of core myopathy with heart disease.

Chauveau C, Bonnemann CG, Julien C, Kho AL, Marks H, Talim B, Maury P, Arne-Bes MC, Uro-Coste E, Alexandrovich A, Vihola A, Schafer S, Kaufmann B, Medne L, Hübner N, Foley AR, Santi M, Udd B, Topaloglu H, Moore SA, Gotthardt M, Samuels ME, Gautel M, Ferreiro A.

Hum Mol Genet. 2014 Feb 15;23(4):980-91. doi: 10.1093/hmg/ddt494. Epub 2013 Oct 8.

38.

Transcription regulation and chromatin structure in the pluripotent ground state.

Marks H, Stunnenberg HG.

Biochim Biophys Acta. 2014 Mar;1839(3):129-37. doi: 10.1016/j.bbagrm.2013.09.005. Epub 2013 Oct 2. Review.

PMID:
24096207
39.

Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells.

Habibi E, Brinkman AB, Arand J, Kroeze LI, Kerstens HH, Matarese F, Lepikhov K, Gut M, Brun-Heath I, Hubner NC, Benedetti R, Altucci L, Jansen JH, Walter J, Gut IG, Marks H, Stunnenberg HG.

Cell Stem Cell. 2013 Sep 5;13(3):360-9. doi: 10.1016/j.stem.2013.06.002. Epub 2013 Jul 11.

40.

Kinetics model comparison for the inactivation of Salmonella serotypes Enteritidis and Oranienburg in 10% salted liquid whole egg.

Gurtler JB, Marks HM, Bailey RB, Juneja V, Jones DR.

Foodborne Pathog Dis. 2013 Jun;10(6):492-9. doi: 10.1089/fpd.2012.1366.

PMID:
23763579
41.

Phenotypic variability of a likely FA2H founder mutation in a family with complicated hereditary spastic paraplegia.

Donkervoort S, Dastgir J, Hu Y, Zein WM, Marks H, Blackstone C, Bönnemann CG.

Clin Genet. 2014 Apr;85(4):393-5. doi: 10.1111/cge.12185. Epub 2013 Jun 10. No abstract available.

42.

Modeling uncertainty of estimated illnesses attributed to non-O157:H7 Shiga toxin-producing escherichia coli and its impact on illness cost.

Marks HM, Tohamy SM, Tsui F.

J Food Prot. 2013 Jun;76(6):945-52. doi: 10.4315/0362-028X.JFP-12-409.

PMID:
23726188
43.

The PinkThing for analysing ChIP profiling data in their genomic context.

Nielsen FG, Kooyman M, Kensche P, Marks H, Stunnenberg H, Huynen M.

BMC Res Notes. 2013 Apr 4;6:133. doi: 10.1186/1756-0500-6-133.

44.

SUMOylation regulates the homologous to E6-AP carboxyl terminus (HECT) ubiquitin ligase Rsp5p.

Novoselova TV, Rose RS, Marks HM, Sullivan JA.

J Biol Chem. 2013 Apr 12;288(15):10308-17. doi: 10.1074/jbc.M112.424234. Epub 2013 Feb 26.

45.

Correction of a short cardiac PR interval in a 12-year-old girl with late-onset Pompe disease following enzyme replacement therapy.

Fernández C, Legido A, Jethva R, Marks HG.

Genet Med. 2012 Aug;14(8):757-8. doi: 10.1038/gim.2012.61. No abstract available.

PMID:
22863876
46.

The transcriptional and epigenomic foundations of ground state pluripotency.

Marks H, Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H, Nichols J, Kranz A, Stewart AF, Smith A, Stunnenberg HG.

Cell. 2012 Apr 27;149(3):590-604. doi: 10.1016/j.cell.2012.03.026.

47.

Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk.

Brinkman AB, Gu H, Bartels SJ, Zhang Y, Matarese F, Simmer F, Marks H, Bock C, Gnirke A, Meissner A, Stunnenberg HG.

Genome Res. 2012 Jun;22(6):1128-38. doi: 10.1101/gr.133728.111. Epub 2012 Mar 30.

48.

Carbohydrate restricted diet in conjunction with metformin and liraglutide is an effective treatment in patients with deteriorated type 2 diabetes mellitus: Proof-of-concept study.

Müller JE, Sträter-Müller D, Marks HJ, Gläsner M, Kneppe P, Clemens-Harmening B, Menker H.

Nutr Metab (Lond). 2011 Dec 23;8(1):92. doi: 10.1186/1743-7075-8-92.

49.

Non-invasive evaluation of buccal respiratory chain enzyme dysfunction in mitochondrial disease: comparison with studies in muscle biopsy.

Goldenthal MJ, Kuruvilla T, Damle S, Salganicoff L, Sheth S, Shah N, Marks H, Khurana D, Valencia I, Legido A.

Mol Genet Metab. 2012 Mar;105(3):457-62. doi: 10.1016/j.ymgme.2011.11.193. Epub 2011 Nov 30.

PMID:
22189081
50.

An RNA-Seq strategy to detect the complete coding and non-coding transcriptome including full-length imprinted macro ncRNAs.

Huang R, Jaritz M, Guenzl P, Vlatkovic I, Sommer A, Tamir IM, Marks H, Klampfl T, Kralovics R, Stunnenberg HG, Barlow DP, Pauler FM.

PLoS One. 2011;6(11):e27288. doi: 10.1371/journal.pone.0027288. Epub 2011 Nov 10.

Supplemental Content

Support Center